Safety of once-daily aminoglycosides in older people

Journal of the American Geriatrics Society

Volumn 48, Issue 7, 2000, Pages 857-859

  Susser, Ziv ^a   Raveh, David ^a   Yinnon, Amos M ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CREATININE; GENTAMICIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG SAFETY; ELDERLY CARE; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; RISK FACTOR; SEPSIS; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 0033947922     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2000.tb04772.x     Document Type: Letter

References (21)

1. Gilbert DN,. Aminoglycosides. In:, Mandell GL, Bennett JE, Dolin R., eds. Principles and Practice of Infectious Diseases, 4th Ed. New York: Churchill Livingstone, 1995, pp 279-306.
2. Mingeot-Leclercq MP, Tulkens PM,. Aminoglycosides: Nephrotoxicity. Anti-microb Agents Chemother 1999; 43: 1003-1012.
3. Ali MZ, Goetz MB,. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 796-809.
4. Moore RD, Smith CR, Lipsky JJ, et al., Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984; 100: 352-357.
5. Sawyers CL, Moore RD, Lerner SA, Smith CR,. A model for predicting nephrotoxicity in patients treated with aminoglycosides. J Infect Dis 1986; 153: 1062-1068.
6. Smith CR, Moore RD, Lietman PS,. Studies of risk factors for aminoglycoside nephrotoxicity. Am J Kidney Dis 1986; 8: 308-313.
7. Prins JM, Bueller HR, Kuijper EJ, et al, Tange RA, Speelman P.,. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341: 335-339.
8. Sturm AW,. Netilmicin in the treatment of Gram-negative bacteremia: Single daily versus multiple daily dosage. J Infect Dis 1989; 159: 931-937.
9. Vogelman BS, Craig WA,. Postantibiotic effects. J Antimicrob Chemother 1985; 15 (Suppl A): 37-46.
10. Hatala R., Dinh T., Cook DJ,. Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis. Ann Intern Med 1996; 124: 717-725.
11. Barza M., Ioannidis JPA, Cappelleri JC, Lau J.,. Single or multiple daily doses of aminoglycosides: A meta-analysis. BMJ 1996; 312: 338-345.
12. Gilbert DN,. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991; 35: 399-405.
13. Cockcroft DW, Gault ME,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Gault MH, Longerich LL, Harnett JD, Wesolowski C.,. Predicting glomerular function from adjusted serum creatinine. Nephron 1992; 62: 249-256.
15. Lietman PS,. Liver disease, aminoglycoside antibiotics, and renal dysfunction. Hepatology 1988; 4: 966-968.
16. Thompson JR, Simonsen R., Spindler MA, et al., Protective effect of KCl loading in gentamicin nephrotoxicity. Am J Kidney Dis 1990; 15: 583-591.
17. Marre R., Tarara N., Louton T., Sack K.,. Age-dependent nephrotoxicity and the pharmacokinetics of gentamicin in rats. Eur J Pediatr 1980; 133: 25-29.
18. Provoost AP, Adejuyigbe O., Wolff ED,. Nephrotoxicity of aminoglycosides in young and adult rats. Pediatr Res 1985; 19: 1191-1196.
19. Beauchamp D., Gourde P., Thereault G., Bergeron MG,. Age-dependent gentamicin experimental nephrotoxicity. J Pharmacol Exp Ther 1992; 260: 444-449.
20. McMartin DN, Engel SG,. Effect of aging on gentamicin nephrotoxicity in rats. Res Commun Chem Pathol Pharmacol 1982; 38: 193-207.
21. Fujita K., Sayama T., Abe S., et al., Age-dependent aminoglycoside nephrotoxicity. J Urol 1985; 134: 596-597.